Cardiac origin of smooth muscle cells in the inflow tract

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 2, 2011, Pages 337-345

  Nakano, Haruko ^a   Williams, Estrelania ^a   Hoshijima, Masahiko ^b   Sasaki, Mika ^c,d   Minamisawa, Susumu ^e   Chien, Kenneth R ^c,d   Nakano, Atsushi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD UNIVERSITY   (United States)

^e WASEDA UNIVERSITY   (Japan)

Author keywords

Cardiogenesis; Great vessel; Myogenic progenitor; Plasticity; Smooth muscle

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; CRE RECOMBINASE; PROTEIN ISL1; SARCOLIPIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELL POPULATION; DEVELOPMENTAL BIOLOGY; EMBRYO; GESTATION PERIOD; HEART ATRIUM; HEART BLOOD VESSEL; HEART DEVELOPMENT; HEART MUSCLE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; ENDOTHELIAL CELLS; GENE KNOCK-IN TECHNIQUES; HOMEODOMAIN PROTEINS; MICE; MICE, TRANSGENIC; MUSCLE PROTEINS; MYOBLASTS, CARDIAC; MYOCARDIUM; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; PROTEOLIPIDS;

EID: 79151469074     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.10.009     Document Type: Article

References (41)

1. + cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 2006, 11:723-732.
2. + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006, 127:1151-1165.
3. Wu S.M., Fujiwara Y., Cibulsky S.M., Clapham D.E., Lien C.L., Schultheiss T.M., et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006, 127:1137-1150.
4. + embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
5. Garry D.J., Olson E.N. A common progenitor at the heart of development. Cell 2006, 127:1101-1104.
6. Kattman S.J., Adler E.D., Keller G.M. Specification of multipotential cardiovascular progenitor cells during embryonic stem cell differentiation and embryonic development. Trends Cardiovasc Med 2007, 17:240-246.
7. Martin-Puig S., Wang Z., Chien K.R. Lives of a heart cell: tracing the origins of cardiac progenitors. Cell Stem Cell 2008, 2:320-331.
8. Cai C.L., Liang X., Shi Y., Chu P.H., Pfaff S.L., Chen J., et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 2003, 5:877-889.
9. Laugwitz K.L., Moretti A., Caron L., Nakano A., Chien K.R. Islet1 cardiovascular progenitors: a single source for heart lineages?. Development 2008, 135:193-205.
10. Kelly R.G., Brown N.A., Buckingham M.E. The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev Cell 2001, 1:435-440.
11. Mjaatvedt C.H., Nakaoka T., Moreno-Rodriguez R., Norris R.A., Kern M.J., Eisenberg C.A., et al. The outflow tract of the heart is recruited from a novel heart-forming field. Dev Biol 2001, 238:97-109.
12. Waldo K.L., Kumiski D.H., Wallis K.T., Stadt H.A., Hutson M.R., Platt D.H., et al. Conotruncal myocardium arises from a secondary heart field. Development 2001, 128:3179-3188.
13. Dodou E., Verzi M.P., Anderson J.P., Xu S.M., Black B.L. Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development 2004, 131:3931-3942.
14. Waldo K.L., Hutson M.R., Ward C.C., Zdanowicz M., Stadt H.A., Kumiski D., et al. Secondary heart field contributes myocardium and smooth muscle to the arterial pole of the developing heart. Dev Biol 2005, 281:78-90.
15. Sun Y., Liang X., Najafi N., Cass M., Lin L., Cai C.L., et al. Islet 1 is expressed in distinct cardiovascular lineages, including pacemaker and coronary vascular cells. Dev Biol 2007, 304:286-296.
16. Galli D., Dominguez J.N., Zaffran S., Munk A., Brown N.A., Buckingham M.E. Atrial myocardium derives from the posterior region of the second heart field, which acquires left-right identity as Pitx2c is expressed. Development 2008, 135:1157-1167.
17. Odermatt A., Taschner P.E., Scherer S.W., Beatty B., Khanna V.K., Cornblath D.R., et al. Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease. Genomics 1997, 45:541-553.
18. Minamisawa S., Wang Y., Chen J., Ishikawa Y., Chien K.R., Matsuoka R. Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling. J Biol Chem 2003, 278:9570-9575.
19. Babu G.J., Bhupathy P., Carnes C.A., Billman G.E., Periasamy M. Differential expression of sarcolipin protein during muscle development and cardiac pathophysiology. J Mol Cell Cardiol 2007, 43:215-222.
20. Xu H., Chen L., Baldini A. In vivo genetic ablation of the periotic mesoderm affects cell proliferation survival and differentiation in the cochlea. Dev Biol 2007, 310:329-340.
21. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999, 21:70-71.
22. Vintersten K., Monetti C., Gertsenstein M., Zhang P., Laszlo L., Biechele S., et al. Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis 2004, 40:241-246.
23. Soufan A.T., van den Hoff M.J., Ruijter J.M., de Boer P.A., Hagoort J., Webb S., et al. Reconstruction of the patterns of gene expression in the developing mouse heart reveals an architectural arrangement that facilitates the understanding of atrial malformations and arrhythmias. Circ Res 2004, 95:1207-1215.
24. Anderson R.H., Brown N.A., Moorman A.F. Development and structures of the venous pole of the heart. Dev Dyn 2006, 235:2-9.
25. Mommersteeg M.T., Soufan A.T., de Lange F.J., van den Hoff M.J., Anderson R.H., Christoffels V.M., et al. Two distinct pools of mesenchyme contribute to the development of the atrial septum. Circ Res 2006, 99:351-353.
26. Moorman A.F., Christoffels V.M., Anderson R.H., van den Hoff M.J. The heart-forming fields: one or multiple?. Philos Trans R Soc Lond B Biol Sci 2007, 362:1257-1265.
27. Snarr B.S., O'Neal J.L., Chintalapudi M.R., Wirrig E.E., Phelps A.L., Kubalak S.W., et al. Isl1 expression at the venous pole identifies a novel role for the second heart field in cardiac development. Circ Res 2007, 101:971-974.
28. Snarr B.S., Wirrig E.E., Phelps A.L., Trusk T.C., Wessels A. A spatiotemporal evaluation of the contribution of the dorsal mesenchymal protrusion to cardiac development. Dev Dyn 2007, 236:1287-1294.
29. Kruithof B.P., van den Hoff M.J., Wessels A., Moorman A.F. Cardiac muscle cell formation after development of the linear heart tube. Dev Dyn 2003, 227:1-13.
30. Bu L., Jiang X., Martin-Puig S., Caron L., Zhu S., Shao Y., et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 2009, 460:113-117.
31. Dyer L.A., Kirby M.L. The role of secondary heart field in cardiac development. Dev Biol 2009, 336:137-144.
32. Buckingham M., Meilhac S., Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 2005, 6:826-835.
33. Soufan A.T., van den Berg G., Ruijter J.M., de Boer P.A., van den Hoff M.J., Moorman A.F. Regionalized sequence of myocardial cell growth and proliferation characterizes early chamber formation. Circ Res 2006, 99:545-552.
34. Christoffels V.M., Mommersteeg M.T., Trowe M.O., Prall O.W., de Gier-de Vries C., Soufan A.T., et al. Formation of the venous pole of the heart from an Nkx2-5-negative precursor population requires Tbx18. Circ Res 2006, 98:1555-1563.
35. Mommersteeg M.T., Brown N.A., Prall O.W., de Gier-de Vries C., Harvey R.P., Moorman A.F., et al. Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ Res 2007, 101:902-909.
36. Nakano A., Nakano H., Chien K.R. Multipotent islet-1 cardiovascular progenitors in development and disease. Cold Spring Harb Symp Quant Biol 2008, 73:297-306.
37. Jais P., Haissaguerre M., Shah D.C., Chouairi S., Gencel L., Hocini M., et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997, 95:572-576.
38. Haissaguerre M., Jais P., Shah D.C., Takahashi A., Hocini M., Quiniou G., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998, 339:659-666.
39. Haissaguerre M., Shah D.C., Jais P., Hocini M., Yamane T., Deisenhofer I., et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000, 102:2463-2465.
40. Chen P.S., Chou C.C., Tan A.Y., Zhou S., Fishbein M.C., Hwang C., et al. The mechanisms of atrial fibrillation. J Cardiovasc Electrophysiol 2006, 17(Suppl 3):S2-S7.
41. Ocorr K., Reeves N.L., Wessells R.J., Fink M., Chen H.S., Akasaka T., et al. KCNQ potassium channel mutations cause cardiac arrhythmias in Drosophila that mimic the effects of aging. Proc Natl Acad Sci U S A 2007, 104:3943-3948.